STATE OF WISCONSIN
Controlled Substances Board
IN THE MATTER OF RULE-MAKING PROCEEDINGS BEFORE THE
CONTROLLED SUBSTANCES BOARD
ORDER OF THE CONTROLLED SUBSTANCES BOARD
ADOPTING RULES
(CLEARINGHOUSE RULE 15-00
7
)
ORDER
An order of the
Controlled Substances Board
to
create CSB 2.3
7
relating to
re
scheduling
hydrocodone combination products.
Analysis prepared by the Department of
Safety and Professional Services
.
---------------------------------------------------------------------------------------------------------------------
ANALYSIS
Statutes interpreted:
s.
961.
18
, Stats.
Explanation of agency authority:
961.11(4)
If a substance is designated, rescheduled or deleted as a controlled substance under federal law and notice thereof is given to the controlled substances board, the board by affirmative action shall similarly treat the substance under this chapter after the expiration of 30 days from the date of publication in the federal register of a final order designating the substance as a controlled substance or rescheduling or deleting the substance or from the date of
issuance
of an order of temporary scheduling under
21 USC 811
(h), unless within that 30−day period, the board or an interested party objects to the treatment of the substance. If no objection is made, the board shall promulgate, without making the determinations or findings required by subs. (1), (1m), (1r) and (2) or s.
961.13
,
961.15
,
961.17
,
961.19
or
961.21
, a final rule, for which notice of proposed rulemaking is omitted, designating, rescheduling,
temporarily scheduling or deleting the substance. If an objection is made the board shall publish notice of receipt of the objection and the reasons for objection and afford all interested parties an opportunity to be heard. At the conclusion of the hearing, the board shall make a determination with respect to the treatment of the substance as provided in subs. (1), (1m), (1r) and (2) and shall publish its decision, which shall be final unless altered by statute. Upon publication of an objection to the treatment by the board, action by the board under this chapter is stayed until the board promulgates a rule under sub. (2).
Related statute or rule:
N/A
Plain language analysis:
The Controlled Substances Board did not receive an objection to treating
hydrocodone combination products
as a schedule
II instead of schedule III
under
ch.
961
, Stats
.
based
upon the federal scheduling. The Controlled Substances Board took affirmative action on
October 7
, 201
4
to similarly treat
hydrocodone combination products
under chapter 961 effective
November
1, 2014 to allow for publication in the Administrative Register. The Affirmative Action
Order
will expire upon promulgation of a final rule.
This rule
repeals sections 961.18(5
)(
c) and (d) which reschedules hydrocodone combination products from a schedule III to a schedule II.
Summary of, and comparison with, existing or proposed federal regulation:
On
August 22
, 2014, the United States
Department of Justice
, Drug Enforcement Administration published its final rule in the Federal Register
rescheduling hydrocodone combination products from a schedule III to a schedule II
of the federal Controlle
d
Substances Act. The scheduling action was effective
October 6
, 2014.
Comparison with rules in adjacent states:
Illinois
: Illinois has not rescheduled hydrocodone combination products.
Iowa
: Iowa is in the process of promulgating an administrative rule to amend the Iowa statutes to reschedule hydrocodone combination products from schedule III to schedule II.
Michigan
: Michigan has not rescheduled hydrocodone combination products.
Minnesota:
Minnesota has not rescheduled hydrocodone combination products.
Summary of factual data and analytical methodologies:
The methodology was to
reschedule hydrocodone combination products
to conform
with
the federal Controlled Substances Act.
Analysis and supporting documents used to determine effect on small business or in preparation of economic impact
analysis
:
None.
Fiscal Estimate and Economic Impact Analysis:
The Fiscal Estimate and Economic Impact Analysis is attached.
Effect on small business
:
These proposed rules
do
not
have
an economic impact on small businesses, as defined in s.
227.114 (1)
, Stats. The Department’s Regulatory Review Coordinator may be contacted by email at
Eric.Esser
@wisconsin.gov
, or by calling (608) 26
7-2435
.
Agency contact person
:
Sharon Henes, Administrative Rules Coordinator
, Department of
Safety and Professional Services
, Division of Board Services, 1400 East Washington Avenue, Room 151, P.O. Box 8935, Madison, Wisconsin 53708; telephone 608-
261-2377
; email at
Sharon.Henes
@wisconsin.gov
.
---------------------------------------------------------------------------------------------------------------------
TEXT OF RULE
Section
1. CSB 2.3
7
is created to read:
CSB 2.3
7
Rescheduling of hydrocodone combination products
. Section 961.
18(5
)(
c) and (d), Stats.
are
repealed.
Section
2
. EFFECTIVE DATE.
The rules adopted in this order shall take effect on the first day of the month following publication in the
Wisconsin
administrative register, pursuant to s.
227.22 (2) (intro.)
, Stats.
---------------------------------------------------------------------------------------------------------------------
(END OF TEXT OF RULE)
---------------------------------------------------------------------------------------------------------------------
